Silexion Therapeutics Corp (SLXNW) › Operating IncomeSilexion Therapeutics Corp (SLXNW) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$4.68M2024: -$12.57M2025: -$11.63M-$11.63M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$11.63M+7.5%2024-$12.57M-168.6%2023-$4.68M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share